Belsky Marc 4
4 · Kezar Life Sciences, Inc. · Filed Jan 11, 2021
Insider Transaction Report
Form 4
Belsky Marc
Chief Financial Officer
Transactions
- Award
Employee Stock Option (right to buy)
2021-01-08+220,000→ 220,000 totalExercise: $5.45Exp: 2031-01-07→ Common Stock (220,000 underlying)
Footnotes (1)
- [F1]One forty-eighth (1/48th) of the shares shall vest on a monthly basis commencing on January 1, 2021, subject to the Reporting Person continuing to provide service through each such date.